Gentherm (THRM) Cash & Equivalents (2010 - 2026)

Gentherm has reported Cash & Equivalents for 17 years, with the latest figure at $177.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 8.74% year-over-year to $177.4 million; the trailing twelve-month figure through Mar 2026 stood at $177.4 million (up 8.74% YoY), and the FY2025 full-year result was $160.8 million, up 19.9% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $177.4 million, up from $160.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $177.9 million in Q1 2022, with the low at $123.5 million in Q2 2024.
• Average Cash & Equivalents over 5 years is $152.0 million, with a median of $154.2 million recorded in 2025.
• Year-over-year, Cash & Equivalents dropped 28.67% in 2022 and surged 30.4% in 2025.
• Tracing THRM's Cash & Equivalents over 5 years: stood at $153.9 million in 2022, then decreased by 2.74% to $149.7 million in 2023, then slipped by 10.38% to $134.1 million in 2024, then rose by 19.9% to $160.8 million in 2025, then advanced by 10.3% to $177.4 million in 2026.
• The last three Cash & Equivalents figures came in at $177.4 million (Q1 2026), $160.8 million (Q4 2025), and $154.2 million (Q3 2025), per Business Quant data.

Peer Comparison